![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/625221-134x100.jpg)
Real-time release testing requires that every tablet meet quality specifications before it leaves the line. This overview examines how in-blister 3DP manufacturing, combined with continuous PAT monitoring and Pharma 4.0 data infrastructure, supports 100% tablet-level inspection and traceability from powder to finished package.